Evidence map›Paper›PMID 33139557›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment.

Jiang Ouyang, Xiaoyuan Ji, Xingcai Zhang, Chan Feng, Zhongmin Tang, Na Kong, Angel Xie, Junqing Wang, Xinbing Sui, Liu Deng and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
22.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 369 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Investigating the Wound Healing Potential of CuCOBiological trace element research · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Jiang OuyangCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Xiaoyuan JiCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Xingcai ZhangJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.ORCID 0000-0001-7114-1095
Chan FengCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Zhongmin TangCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-1532-8004
Na KongCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Angel XieCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Junqing WangCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Xinbing SuiCollege of Pharmacy, School of Medicine, Hangzhou Normal University, 311121 Hangzhou, Zhejiang, China.ORCID 0000-0001-7330-0467
Liu DengCollege of Chemistry and Chemical Engineering, Central South University, 410083 Changsha, Hunan, China.
Younian LiuCollege of Chemistry and Chemical Engineering, Central South University, 410083 Changsha, Hunan, China.ORCID 0000-0002-7078-5937
Jong Seung KimDepartment of Chemistry, Korea University, 02841 Seoul, Korea.ORCID 0000-0003-3477-1172
Yihai CaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, Sweden.ORCID 0000-0003-1308-0065
Wei TaoCenter for Nanomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; wtao@bwh.harvard.edu.ORCID 0000-0002-4277-3728
Brigham and Women's Hospital · USCentral South University · CNHangzhou Normal University · CNHarvard University · USKarolinska Institutet · SEKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of diabetic ulcer (DU) remains a major clinical challenge due to the complex wound-healing milieu that features chronic wounds, impaired angiogenesis, persistent pain, bacterial infection, and exacerbated inflammation. A strategy that effectively targets all these issues has proven elusive. Herein, we use a smart black phosphorus (BP)-based gel with the characteristics of rapid formation and near-infrared light (NIR) responsiveness to address these problems. The in situ sprayed BP-based gel could act as 1) a temporary, biomimetic "skin" to temporarily shield the tissue from the external environment and accelerate chronic wound healing by promoting the proliferation of endothelial cells, vascularization, and angiogenesis and 2) a drug "reservoir" to store therapeutic BP and pain-relieving lidocaine hydrochloride (Lid). Within several minutes of NIR laser irradiation, the BP-based gel generates local heat to accelerate microcirculatory blood flow, mediate the release of loaded Lid for "on-demand" pain relief, eliminate bacteria, and reduce inflammation. Therefore, our study not only introduces a concept of in situ sprayed, NIR-responsive pain relief gel targeting the challenging wound-healing milieu in diabetes but also provides a proof-of-concept application of BP-based materials in DU treatment.

Indexed as

Photothermal TherapyAnesthetics, LocalAnimalsCell LineCell ProliferationDiabetes Mellitus, ExperimentalDiabetic FootDrug Evaluation, PreclinicalEndothelial CellsFibrinogenGelsHumansHuman Umbilical Vein Endothelial CellsLidocaineMaleMice, Inbred BALB CAnesthetics, LocalFibrinogenGelsLidocainePhosphorusSmart MaterialsThrombinanalgesicblack phosphorusdiabetic ulcerfibrin gelwound healing

Identifiers

PMID33139557
PMCPMC7682336
OpenAlexW3095717442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.